Factors predicting the use of immunotherapy for patients with advanced melanoma.

被引：0
|
作者：
Joseph, Richard Wayne
Shillington, Alicia
Macahilig, Cynthia
Diede, Scott J.
Dave, Vaidehi
Harshaw, Qing
Liu, Frank Xiaoqing
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] EPI Q Inc, Oak Brook, IL USA
[3] Med Data Analyt, Parsippany, NJ USA
[4] Merck Co Inc, Kenilworth, NJ USA
[5] Merck & Co Inc, North Wales, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9571
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase Ib study of napabucasin plus weekly paclitaxel in patients with advanced melanoma.
    Edenfield, William Jeffery
    Becerra, Carlos
    Braiteh, Fadi S.
    Spira, Alexander I.
    Sullivan, Ryan J.
    Panella, Timothy J.
    Li, Wei
    Huang, Janet
    Li, Youzhi
    Flaherty, Keith
    Hitron, Matthew
    Li, Chiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.
    Mehnert, Janice M.
    Semlani, Neha
    Wen, Yvonne
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Adams, Shari
    Stein, Mark N.
    Ross, Mikel
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    Chen, Suzie
    Goydos, James S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Use of scintigraphy to define the lymphatic flow pattern in patients with malignant melanoma.
    Fraile, M
    Ferrandiz, C
    Paradelo, C
    Alastrue, A
    Riba, J
    Rull, M
    Vaquero, M
    Vigatà, X
    Fernández, M
    Luque, MT
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (04): : S85 - S85
  • [44] Use of ipilimumab in patients with metastatic melanoma. Experience at the Medica Sur Hospital
    Manuel Ruiz-Morales, Jose
    Rafael Rodriguez-Cid, Jeronimo
    Alvarado-Luna, Gabriela
    Green-Renner, Dan
    Motola-Kuba, Daniel
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (03): : 157 - 161
  • [45] Adoptive Immunotherapy of Advanced Melanoma
    Ronnie Shapira-Frommer
    Jacob Schachter
    [J]. Current Treatment Options in Oncology, 2012, 13 : 340 - 353
  • [46] Adoptive Immunotherapy of Advanced Melanoma
    Shapira-Frommer, Ronnie
    Schachter, Jacob
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (03) : 340 - 353
  • [47] Pathway-flux based biomarker for immunotherapy response in melanoma.
    Li, Jian
    Mei, Qi
    Cheng, Weiting
    Hu, Guangyuan
    Yuan, Xianglin
    Mansmann, Ulrich Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Efficacy of immunotherapy and sequencing of checkpoint inhibition for metastatic ocular melanoma.
    Abhyankar, Anuja
    Maharaj, Satish
    Miller, Donald M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Identification of RPTOR mutation as a novel predictor of efficacious immunotherapy in melanoma.
    Li, Yongzhao
    Zhang, Qin
    Tan, Yuan
    Duan, Qianqian
    Sun, Tingting
    Qi, Chuang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Baseline steroids impair immunotherapy efficacy in a mouse model of melanoma.
    Ferreira, Michelle
    Daniels, Drew
    Bosenberg, Marcus
    [J]. CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
12345